Evidence map›Paper›PMID 36839969›Full record

ArticlePharmaceutics2023

Anti-

Jimena Borgo, Orlando G Elso, Jessica Gomez, Mauro Coll, Cesar A N Catalán, Juan Mucci, Guzmán Alvarez, Lía M Randall, Patricia Barrera, Emilio L Malchiodi and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Extracts and Terpenoids fromMolecules (Basel, Switzerland) · 2024
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Jimena BorgoInstituto de Química y Metabolismo del Fármaco (IQUIMEFA), CONICET-Universidad de Buenos Aires, Junín 956, piso 2, Buenos Aires C1113AAD, Argentina.
Orlando G ElsoCátedra de Farmacognosia, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956, piso 2, Buenos Aires C1113AAD, Argentina.
Jessica GomezFacultad de Ciencias Médicas, Instituto de Histología y Embriología "Dr. Mario H. Burgos" (IHEM), Universidad Nacional de Cuyo-CONICET, CC 56, Mendoza 5500, Argentina.
Mauro CollFacultad de Ciencias Médicas, Instituto de Histología y Embriología "Dr. Mario H. Burgos" (IHEM), Universidad Nacional de Cuyo-CONICET, CC 56, Mendoza 5500, Argentina.
Cesar A N CatalánInstituto de Química Orgánica, Facultad de Bioquímica, Química y Farmacia, Universidad Nacional de Tucumán, Ayacucho 471, San Miguel de Tucumán, Tucumán T4000INI, Argentina.
Juan MucciInstituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín-CONICET, Buenos Aires 5500, Argentina.
Guzmán AlvarezLaboratorio de Moléculas Bioactivas, Departamento de Ciencias Biológicas, CENUR Litoral Norte, Universidad de la República, Paysandú 60000, Uruguay.ORCID 0000-0001-8385-6100
Lía M RandallLaboratorio de Moléculas Bioactivas, Departamento de Ciencias Biológicas, CENUR Litoral Norte, Universidad de la República, Paysandú 60000, Uruguay.ORCID 0000-0002-7715-1195
Patricia BarreraFacultad de Ciencias Médicas, Instituto de Histología y Embriología "Dr. Mario H. Burgos" (IHEM), Universidad Nacional de Cuyo-CONICET, CC 56, Mendoza 5500, Argentina.
Emilio L MalchiodiCátedra de Inmunología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956, piso 4, Buenos Aires C1113AAD, Argentina.ORCID 0000-0001-7501-3330
Augusto E BivonaCátedra de Inmunología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956, piso 4, Buenos Aires C1113AAD, Argentina.ORCID 0000-0002-0520-0226
María Florencia MartiniInstituto de Química y Metabolismo del Fármaco (IQUIMEFA), CONICET-Universidad de Buenos Aires, Junín 956, piso 2, Buenos Aires C1113AAD, Argentina.
Valeria P SülsenInstituto de Química y Metabolismo del Fármaco (IQUIMEFA), CONICET-Universidad de Buenos Aires, Junín 956, piso 2, Buenos Aires C1113AAD, Argentina.ORCID 0000-0002-9322-5748
Consejo Nacional de Investigaciones Científicas y Técnicas · ARUniversidad de la República de Uruguay · UYNational University of Tucumán · AR

Funding

Agencia Nacional de Promoción Científica y Tecnológica PICT-2018-2861Agencia Nacional de Promoción Científica y Tecnológica PICT 2020--SERIEA-03061Agencia Nacional de Promoción Científica y Tecnológica PPM-ANLAP-2021National Scientific and Technical Research Council 11220150100158CONational Scientific and Technical Research Council PUE-0017CO-2016University of Buenos Aires 20020130100788BAUniversity of Buenos Aires 20020170100316BA
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

2-oxo-8-deoxyligustrinmolecular targetsprolyl oligopeptidasesanthemoidin Csesquiterpene lactonesStevia alpinaStevia satureiifolia var satureiifoliatrypanocidal activity

Identifiers

PMID36839969
PMCPMC9961625
OpenAlexW4320919721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.